“Weight loss quality is a new concept….The discussion no longer revolves around the lack of adequate efficacy but rather ...

British Columbia's Ministry of Health is limiting the sales of two more diabetes drugs to curb their off-label use for weight ...

Researchers found that tirzepatide, a medication primarily used for treating type 2 diabetes and weight loss, reduced body ...

How does tirzepatide work? Tirzepatide mimics hormones that regulate appetite and glucose metabolism, promoting weight loss and improving insulin sensitivity. What are the benefits of using GetSimpli?

Postmenopausal women on tirzepatide show lower weight loss than those typically seen with the obesity drug, but weight loss ...

A 6-week randomized trial found that tirzepatide significantly reduced energy intake, appetite, and cravings in adults with overweight or obesity, outperforming liraglutide and placebo. Brain ...

While they share similarities, there are differences, particularly between the drugs semaglutide and tirzepatide.

Palatin Reports Positive Appetite Suppression Results From Phase 2 Obesity Study of MC4R Agonist Bremelanotide and Tirzepatide Apr. 17, 2025 7:30 AM ET Palatin Technologies, Inc. (PTN) ...

Nevertheless, tirzepatide and semaglutide both led to a decrease in the respiratory exchange ratio [1] during the first two weeks of treatment, suggesting an increase in fat oxidation and a ...

Tirzepatide decreased participants’ calorie intake by reducing appetite while increasing fat oxidation. However, the drug did not decrease the slowing down of their metabolic rate usually observed ...

Researchers found that tirzepatide, a medication primarily used for treating type 2 diabetes and weight loss, reduced body weight, food intake and many measures of appetite more than placebo and ...

We're excited with the results, which demonstrated that low-dose bremelanotide matched tirzepatide in appetite suppression, a compelling outcome," said Carl Spana, Ph.D., President and CEO of Palatin.